Petros Pharmaceuticals (PTPI) Stock Chart & Stock Price History $0.03 0.00 (-1.85%) As of 08/4/2025 03:32 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Stock Price Performance The Petros Pharmaceuticals (PTPI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.64%, with a year-to-date return of -99.68%. In the past month, the stock has decreased 8.88%, reflecting recent market activity. As of the latest close, Petros Pharmaceuticals traded at $0.03 with a market cap of $991 thousand and volume of 262,626 shares. Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.30%1 Month Performance-8.88%3 Month Performance-84.93%Year-To-Date Performance-99.68%1 Year Performance-99.64% PTPI Stock Chart for Tuesday, August, 5, 2025 PTPI Chart by TradingView Petros Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$0.03$0.03-1.85%$0.03$0.03262,626 shs$991,000.0008/01/2025$0.03$0.03+7.28%$0.03$0.03686,942 shs$1.01 million07/31/2025$0.03$0.03+9.82%$0.03$0.03862,821 shs$941,000.0007/30/2025$0.03$0.03-4.84%$0.03$0.03138,373 shs$857,000.0007/29/2025$0.03$0.03-3.99%$0.03$0.03323,602 shs$901,000.0007/28/2025$0.03$0.03-2.90%$0.03$0.03483,085 shs$938,000.0007/25/2025$0.03$0.03+3.68%$0.03$0.03361,189 shs$966,000.0007/24/2025$0.03$0.03+1.01%$0.03$0.031.40 million shs$932,000.0007/23/2025$0.03$0.03+8.82%$0.03$0.03120,717 shs$922,000.0007/22/2025$0.03$0.03-2.86%$0.03$0.03146,845 shs$848,000.00 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$0.03$0.03-2.78%$0.03$0.03349,331 shs$872,000.0007/18/2025$0.03$0.03$0.03$0.03273,354 shs$897,000.0007/17/2025$0.03$0.03+1.05%$0.03$0.03462,871 shs$897,000.0007/16/2025$0.03$0.03-2.73%$0.03$0.03343,771 shs$888,000.0007/15/2025$0.03$0.03+6.55%$0.03$0.03258,549 shs$913,000.0007/14/2025$0.03$0.03-3.51%$0.03$0.03312,098 shs$857,000.0007/11/2025$0.03$0.03-2.73%$0.03$0.03663,479 shs$888,000.0007/10/2025$0.03$0.03+4.64%$0.03$0.03120,575 shs$913,000.0007/09/2025$0.03$0.03-6.67%$0.03$0.03743,170 shs$872,000.0007/08/2025$0.03$0.03-5.66%$0.03$0.03763,008 shs$935,000.0007/07/2025$0.03$0.03-8.88%$0.04$0.03593,505 shs$991,000.0007/04/2025$0.03$0.03$0.04$0.03245,089 shs$1.09 million Related Companies NovaBay Pharmaceuticals Stock Chart Titan Pharmaceuticals Stock Chart Windtree Therapeutics Stock Chart Galmed Pharmaceuticals Stock Chart Enveric Biosciences Stock Chart PMGC Stock Chart Lipella Pharmaceuticals Stock Chart UNITY Biotechnology Stock Chart PainReform Stock Chart CERo Therapeutics Stock Chart Receive PTPI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTPI) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTPI Stock Alerts